EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Semaglutide Remodels the Gut Microbiome Beyond Its Appetite‐Suppressing Action: Sex‐Specific Gut‐Brain Axis Implications

Suyeun Byun, Morgan R Sotzen iD, Madison T Bento iD, Mya A Knappenberger iD, Mohammed Asker iD, Justin R Wright, Regina Lamendella, Chunlong Mu iD, Karolina P Skibicka iD

Comprehensive Physiology · 2026-10 · 16 (5)

DOI: 10.1002/cph4.70286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Comprehensive Physiology, online erschienen am 21.10.2026. Verfasst von Suyeun Byun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences Pennsylvania State University State College Pennsylvania USA. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Diabetes and Digestive and Kidney Diseases, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiome communicates bidirectionally with the brain and peripheral metabolic organs to regulate appetite and body weight. Semaglutide (SEMA), a GLP‐1 receptor agonist, produces robust weight loss by reducing food intake, largely through brain GLP‐1 receptors, yet whether its effects on the gut microbiome are secondary to this centrally driven hypophagia is poorly understood. Given the profound impact of SEMA on food intake and body weight, we propose that SEMA treatment reshapes gut microbial composition and that these shifts are correlated with metabolic outcomes. Diet‐induced obese rats received a 4‐week SEMA treatment and gut microbial composition was analyzed using 16S rRNA gene sequencing. To differentiate the impact of reduced food intake associated with SEMA from other effects of the drug treatment on the gut microbiome, a pair‐fed to SEMA group was tested. SEMA significantly reduced body weight gain and food intake in both sexes. Significant SEMA‐induced changes in microbial richness and evenness were detected. Linear discriminant analysis Effect Size (LEfSe) identified enrichment of Firmicutes taxa—particularly members of the Clostridiaceae family—in SEMA‐treated rats, whereas controls showed greater representation of Bacteroidota taxa. Sex‐specific associations between host metabolic parameters and gut microbial composition were also identified. These findings demonstrate profound, not necessarily health positive, partly sex‐specific gut microbial community shifts following GLP‐1 analogue treatment. Many of the changes in the gut microbiota were not simply driven by the decreased food intake. Thus, GLP‐1 analogue treatment engages the gut microbiome through both food intake–dependent (brain‐to‐gut) and intake‐independent pathways.

Schlagwörter

Stichwörter der Autor:innen

glucagon‐like peptide 1gut microbiomegut‐brain axisinterorgan communicationpair‐feedingsemaglutidesex differences

Autor:innen und Institutionen

  • Department of Nutritional Sciences Pennsylvania State University State College Pennsylvania USA.
  • Department of Physiology and Pharmacology Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary Calgary Alberta Canada.
  • Institute of Neuroscience and Physiology, University of Gothenburg Gothenburg Sweden.
  • Wright Labs, LLC Huntingdon Pennsylvania USA.
  • Department of Biology Juniata College Huntingdon Pennsylvania USA.
  • Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine University of Calgary Calgary Alberta Canada.

ORCID-Profile: Morgan R Sotzen, Madison T Bento, Mya A Knappenberger, Mohammed Asker, Chunlong Mu, Karolina P Skibicka

Förderung

  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Canadian Institutes of Health Research
  • Natural Sciences and Engineering Research Council of Canada

Zitieren

APA

Byun, S., Sotzen, M. R., Bento, M. T., Knappenberger, M. A., Asker, M., Wright, J. R., Lamendella, R., Mu, C., & Skibicka, K. P. (2026). Semaglutide Remodels the Gut Microbiome Beyond Its Appetite‐Suppressing Action: Sex‐Specific Gut‐Brain Axis Implications. Comprehensive Physiology, 16(5). https://doi.org/10.1002/cph4.70286

Vancouver

Byun S, Sotzen MR, Bento MT, Knappenberger MA, Asker M, Wright JR, et al. Semaglutide Remodels the Gut Microbiome Beyond Its Appetite‐Suppressing Action: Sex‐Specific Gut‐Brain Axis Implications. Comprehensive Physiology. 2026;16(5). doi:10.1002/cph4.70286

BibTeX
@article{Byun2026,
  author = {Byun, Suyeun and Sotzen, Morgan R and Bento, Madison T and Knappenberger, Mya A and Asker, Mohammed and Wright, Justin R and Lamendella, Regina and Mu, Chunlong and Skibicka, Karolina P},
  title = {Semaglutide Remodels the Gut Microbiome Beyond Its Appetite‐Suppressing Action: Sex‐Specific Gut‐Brain Axis Implications},
  journal = {Comprehensive Physiology},
  year = {2026},
  volume = {16},
  number = {5},
  doi = {10.1002/cph4.70286}
}
Kostenlos starten →